Tetrabutylammonium Fluoride → HCID 16035849, compound

HRID 1987125Notes

Reaction equation

HRID 1987125 reaction equation
[Si]([O:8][CH2:9][CH2:10][C:11]1[CH:12]=[CH:13][C:14]2[CH:30]=[CH:29][C:18]3=[N:19][CH:20]=[C:21]([C:23]4[CH:24]=[N:25][N:26]([CH3:28])[CH:27]=4)[CH:22]=[C:17]3[C:16](=[O:31])[C:15]=2[CH:32]=1)(C(C)(C)C)(C)C.[F-].C([N+](CCCC)(CCCC)CCCC)CCC>O1CCCC1.C(OCC)(=O)C.[Cl-].[Na+].O>[OH:8][CH2:9][CH2:10][C:11]1[CH:12]=[CH:13][C:14]2[CH:30]=[CH:29][C:18]3=[N:19][CH:20]=[C:21]([C:23]4[CH:24]=[N:25][N:26]([CH3:28])[CH:27]=4)[CH:22]=[C:17]3[C:16](=[O:31])[C:15]=2[CH:32]=1

Participants

6

Procedure

7-(2-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-3-(1-methyl-1H-pyrazol-4-yl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (5 mg, 0.011 mmol) was dissolved in 0.5 mL of tetrahydrofuran. Tetrabutylammonium fluoride (0.013 mL of 1.0M in THF, 0.013 mmol) was added and the mixture was stirred at room temperature for 1 hour. The reaction was diluted with ethyl acetate and brine and washed with brine twice. The organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo. Purification via reverse phase HPLC (10-70% acetonitrile/water gradient, 0.05% trifluoroacetic acid modifier) afforded the title compound. 1H NMR (600 MHz, CDCl3) δ 9.01 (d, 1H); 8.58 (s, 1H); 8.16 (d, 1H); 7.92 (s, 1H); 7.81 (s, 1H); 7.59 (dd, 1H); 7.56 (d, 1H); 7.35 (d, 1H); 7.24 (d, 1H); 3.99 (s, 3H); 3.96 (t, 2H); 3.03 (t, 2H). Hydroxyl proton was not observed. LRMS (APCI) calc'd for (C20H18N3O2) [M+H]+, 332.1; found 332.1.

Workup

  1. washwashed with brine twice
  2. dry with materialThe organic layer was dried over magnesium sulfate
  3. filtrationfiltered
  4. concentrationconcentrated in vacuo
  5. customPurification via reverse phase HPLC (10-70% acetonitrile/water gradient, 0.05% trifluoroacetic acid modifier)

Sources & evidence

ORD record
ord-ab7cbbd1efbd48078c76cf15c67cdd31
Source dataset
uspto-grants-2009_06
Patent number
US07550478B2

Reaction notes

Loading…